• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与供体淋巴细胞抗原(DLA)匹配的犬骨髓移植需要多少辐射剂量?

What radiation dose for DLA-identical canine marrow grafts?

作者信息

Storb R, Raff R F, Appelbaum F R, Schuening F W, Sandmaier B M, Graham T C, Thomas E D

机构信息

Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA 98104.

出版信息

Blood. 1988 Oct;72(4):1300-4.

PMID:3048439
Abstract

In view of reported attempts at marrow grafting after nuclear accidents with a broad range of radiation exposures, the present study explored the total-body irradiation (TBI) conditions needed for engraftment in a canine model by using marrow from DLA-identical littermates. Previous studies have shown that such grafts are consistently successful when recipients are exposed to 920 cGy of TBI delivered at a rate of 7 cGy/min from opposing dual cobalt sources. The present TBI doses were all in the lethal range. Five dogs were administered 450 cGy; seven dogs, 600 cGy; five dogs, 700 cGy; and five dogs, 800 cGy of TBI administered at 7 cGy/min. They received a median of 3.3 x 10(8) marrow cells/kg intravenously after completion of radiation. Results showed transient allogeneic marrow engraftment in all dogs administered the lowest dose of TBI studied (450 cGy). Importantly, transient grafts permitted four of five dogs to live long enough for autologous marrow recovery to occur. At increasing radiation doses, 600, 700, and 800 cGy, the risk of graft failure lessened, with 3 of 7, 2 of 5, and 1 of 5 dogs, respectively, showing graft rejection. Fewer dogs survived with autologous marrow recovery, and more showed sustained allogeneic engraftment (4 of 7, 3 of 5, and 4 of 5 dogs, respectively). We conclude that DLA-identical littermate marrow grafts are beneficial in the setting of otherwise lethal radiation exposures, with most dogs either experiencing sustained allogeneic engraftment or surviving with autologous marrow recovery due to the extended support provided by a transient allogeneic graft.

摘要

鉴于有报道称在核事故后进行了一系列不同辐射暴露剂量下的骨髓移植尝试,本研究通过使用来自DLA相同的同窝仔犬的骨髓,探索了犬类模型中实现骨髓植入所需的全身照射(TBI)条件。先前的研究表明,当接受者从相对的双钴源以7 cGy/分钟的速率接受920 cGy的TBI照射时,此类移植始终是成功的。目前的TBI剂量均在致死范围内。五只犬接受了450 cGy的TBI照射;七只犬接受了600 cGy;五只犬接受了700 cGy;五只犬接受了800 cGy的TBI照射,照射速率为7 cGy/分钟。在完成辐射后,它们静脉内接受了中位数为3.3×10⁸个骨髓细胞/千克的移植。结果显示,在接受研究中最低TBI剂量(450 cGy)的所有犬中均出现了短暂的同种异体骨髓植入。重要的是,短暂的移植使得五只犬中有四只存活时间足够长,从而实现了自体骨髓恢复。随着辐射剂量增加到600、700和800 cGy,移植失败的风险降低,分别有7只犬中的3只、5只犬中的2只和5只犬中的1只出现了移植排斥反应。存活并实现自体骨髓恢复的犬数量减少,更多的犬出现了持续的同种异体植入(分别为7只犬中的4只、5只犬中的3只和5只犬中的4只)。我们得出结论,在其他情况下致死性辐射暴露的情况下,DLA相同的同窝仔犬骨髓移植是有益的,由于短暂的同种异体移植提供的延长支持,大多数犬要么经历持续的同种异体植入,要么存活并实现自体骨髓恢复。

相似文献

1
What radiation dose for DLA-identical canine marrow grafts?与供体淋巴细胞抗原(DLA)匹配的犬骨髓移植需要多少辐射剂量?
Blood. 1988 Oct;72(4):1300-4.
2
Comparison of fractionated to single-dose total body irradiation in conditioning canine littermates for DLA-identical marrow grafts.在为同基因骨髓移植对犬类同窝幼崽进行预处理时,分次全身照射与单次全身照射的比较。
Blood. 1989 Aug 15;74(3):1139-43.
3
DLA-identical bone marrow grafts after low-dose total body irradiation: effects of high-dose corticosteroids and cyclosporine on engraftment.
Blood. 1995 Dec 1;86(11):4376-81.
4
Fractionated versus single-dose total body irradiation at low and high dose rates to condition canine littermates for DLA-identical marrow grafts.在低剂量率和高剂量率下,对犬类同窝幼崽进行分次全身照射与单次全身照射,以使其适合接受人类白细胞抗原(HLA)匹配的骨髓移植。 (注:原文中DLA应为HLA之误,DLA是猪白细胞抗原,这里按照骨髓移植中常用的人类白细胞抗原HLA进行翻译)
Blood. 1994 Jun 1;83(11):3384-9.
5
An anti-CD44 antibody does not enhance engraftment of DLA-identical marrow after low-dose total body irradiation.抗CD44抗体不会增强低剂量全身照射后DLA匹配骨髓的植入。
Transpl Immunol. 1996 Dec;4(4):271-4. doi: 10.1016/s0966-3274(96)80047-5.
6
DLA-identical bone marrow grafts after low-dose total body irradiation: the effect of canine recombinant hematopoietic growth factors.低剂量全身照射后DLA相同的骨髓移植:犬重组造血生长因子的作用
Blood. 1994 Nov 15;84(10):3558-66.
7
Delaying DLA-haploidentical hematopoietic cell transplantation after total body irradiation.全身照射后延迟进行供体淋巴细胞抗原半相合造血细胞移植
Biol Blood Marrow Transplant. 2009 Oct;15(10):1244-50. doi: 10.1016/j.bbmt.2009.06.004. Epub 2009 Aug 3.
8
Facilitation of engraftment of DLA-nonidentical marrow by treatment of recipients with monoclonal antibody directed against marrow cells surviving radiation.
Transplantation. 1987 Nov;44(5):607-13. doi: 10.1097/00007890-198711000-00004.
9
Comparing high and low total body irradiation dose rates for minimum-intensity conditioning of dogs for dog leukocyte antigen-identical bone marrow grafts.比较高和低全身照射剂量率,以最小强度对狗进行狗白细胞抗原相同的骨髓移植预处理。
Biol Blood Marrow Transplant. 2013 Nov;19(11):1650-4. doi: 10.1016/j.bbmt.2013.08.007. Epub 2013 Aug 28.
10
Marrow toxicity of fractionated vs. single dose total body irradiation is identical in a canine model.在犬类模型中,分次全身照射与单次全身照射的骨髓毒性相同。
Int J Radiat Oncol Biol Phys. 1993 May 20;26(2):275-83. doi: 10.1016/0360-3016(93)90207-c.

引用本文的文献

1
Evolution of haematopoietic cell transplantation for canine blood disorders and a platform for solid organ transplantation.用于犬血液疾病的造血细胞移植的发展和实体器官移植的平台。
Vet Med Sci. 2021 Nov;7(6):2156-2171. doi: 10.1002/vms3.601. Epub 2021 Aug 14.
2
Developments and translational relevance for the canine haematopoietic cell transplantation preclinical model.犬造血细胞移植临床前模型的发展及转化相关性研究。
Vet Comp Oncol. 2020 Dec;18(4):471-483. doi: 10.1111/vco.12608. Epub 2020 May 26.
3
Animal Models for Preclinical Development of Allogeneic Hematopoietic Cell Transplantation.
异基因造血细胞移植临床前开发的动物模型
ILAR J. 2018 Dec 31;59(3):263-275. doi: 10.1093/ilar/ily006.
4
The hematopoietic system in the context of regenerative medicine.再生医学背景下的造血系统。
Methods. 2016 Apr 15;99:44-61. doi: 10.1016/j.ymeth.2015.08.015. Epub 2015 Aug 28.
5
Allogeneic hematopoietic cell transplantation for myelodysplastic syndrome: the past decade.异基因造血细胞移植治疗骨髓增生异常综合征:过去十年。
Expert Rev Clin Immunol. 2012 May;8(4):373-81. doi: 10.1586/eci.12.18.
6
Role of comorbidities in optimizing decision-making for allogeneic hematopoietic cell transplantation.合并症在异基因造血细胞移植决策优化中的作用。
Mediterr J Hematol Infect Dis. 2010;2(2):e2010015. doi: 10.4084/MJHID.2010.015. Epub 2010 Jun 9.
7
Allogeneic hematopoietic cell transplantation: the state of the art.异基因造血细胞移植:最新进展。
Expert Rev Hematol. 2010 Jun;3(3):285-99. doi: 10.1586/ehm.10.21.
8
Nonmyeloablative allogeneic hematopoietic cell transplantation in patients with acute myeloid leukemia.非清髓性异基因造血细胞移植治疗急性髓系白血病。
J Clin Oncol. 2010 Jun 10;28(17):2859-67. doi: 10.1200/JCO.2009.27.1460. Epub 2010 May 3.
9
Five decades of progress in haematopoietic cell transplantation based on the preclinical canine model.基于临床前犬类模型的造血细胞移植五十年进展。
Vet Comp Oncol. 2007 Mar;5(1):14-30. doi: 10.1111/j.1476-5829.2006.00114.x.
10
Delaying DLA-haploidentical hematopoietic cell transplantation after total body irradiation.全身照射后延迟进行供体淋巴细胞抗原半相合造血细胞移植
Biol Blood Marrow Transplant. 2009 Oct;15(10):1244-50. doi: 10.1016/j.bbmt.2009.06.004. Epub 2009 Aug 3.